Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Insufficient chart data. Estimates will improve as the show charts.
- Per-Episode Audience
Est. listeners per new episode within ~30 days
N/A🎙 Weekly cadence·81 episodes·Last published 1w ago - Monthly Reach
Unique listeners across all episodes (30 days)
N/A - Active Followers
Loyal subscribers who consistently listen
N/A
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 12 epsHosts
Recent guests
Recent episodes
ERJ Podcast August 2026: Fentanyl or morphine for persistent dyspnoea in COPD
Aug 28, 2026
Unknown duration
ERJ Podcast July 2026: Nerandomilast in progressive pulmonary fibrosis
Aug 12, 2026
Unknown duration
ERS Monograph: Thoracic Ultrasound
Aug 10, 2026
Unknown duration
ERJ Podcast June 2026: The ageing lung
Jul 16, 2026
13m 37s
ERJ Podcast May 2026: Mucus plugs in asthma and COPD
May 21, 2026
16m 46s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 8/28/26 | ERJ Podcast August 2026: Fentanyl or morphine for persistent dyspnoea in COPD | As part of the August issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Marlies van Dijk (University of Groningen, Groningen, The Netherlands) about her multicentre randomised crossover trial of fentanyl and morphine for persistent dyspnoea in COPD, published in this issue of the ERJ (https://doi.org/10.1183/13993003.01431-2025). Cite this podcast as: ERJ Podcast August 2026: Fentanyl or morphine for persistent dyspnoea in COPD. Eur Respir J 2026; 68: 26E6802 [https://doi.org/10.1183/13993003.E6802-2026]. | — | ||||||
| 8/12/26 | ERJ Podcast July 2026: Nerandomilast in progressive pulmonary fibrosis | As part of the July issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Associate Editor Marlies Wijsenbeek about data from the whole follow-up period of the FIBRONEER-ILD trial of nerandomilast in progressive pulmonary fibrosis, published in this issue of the ERJ (https://doi.org/10.1183/13993003.01272-2025). English and Japanese versions of the patient podcast to accompany the article are available from: https://publications.ersnet.org/content/erj/68/1/2501899#edit-group-supplementary-material Cite this podcast as: ERJ Podcast July 2026: Nerandomilast in progressive pulmonary fibrosis. Eur Respir J 2026; 68: 26E6801 [https://doi.org/10.1183/13993003.E6801-2026]. | — | ||||||
| 8/10/26 |  ERS Monograph: Thoracic Ultrasound | "Making ultrasound as widespread and as used as the stethoscope... that's the big challenge going forwards" The latest ERS Monograph podcast focuses on an area that is evolving into a cornerstone of respiratory practice: thoracic ultrasound. Guido Marchi (Monograph Early Career Member representative) talks to Guest Editors of the Thoracic Ultrasound Monograph, Vineeth George and Christian B. Laursen. Their discussion covers key milestones and advances in the field, effective training, maintaining skills, research priorities and future opportunities. It is a conversation and, indeed, a book that truly reflects a challenging and inspiring research agenda. | — | ||||||
| 7/16/26 | ageing lungrespiratory health+3 | Melanie Königshoff | Center for Lung Aging and RegenerationDivision of Pulmonary, Allergy, Critical Care and Sleep Medicine+3 | Pittsburgh, PA, USA | ageing lungpulmonary health+3 | — | 13m 37s | ||
| 5/21/26 | mucus plugsasthma+4 | John Fahy | University of California, San FranciscoEuropean Respiratory Journal+1 | — | mucus plugsasthma+6 | — | 16m 46s | ||
| 5/7/26 | BronchiectasisPatient voice+4 | Amelia ShoemarkStefano Aliberti | EMBARCEuropean Respiratory Society+1 | — | Bronchiectasispatient voice+5 | — | 19m 26s | ||
| 5/1/26 | spirometryairflow obstruction+3 | Sanja Stanojevic | Global Initiative for Chronic Obstructive Lung DiseaseGlobal Lung Function Initiative+2 | — | spirometryCOPD+5 | — | 13m 53s | ||
| 3/30/26 | severe asthmamortality+3 | Susanne Hansen | Department of Respiratory Medicine and Infectious DiseasesBispebjerg Hospital+3 | CopenhagenDenmark | severe asthmamortality+3 | — | 12m 00s | ||
| 2/19/26 | COPDasthma+3 | David Halpin | University of Exeter Medical SchoolGlobal Initiative for Chronic Obstructive Lung Disease+2 | — | COPDasthma+5 | — | 16m 23s | ||
| 2/13/26 | chronic coughantitussive development+3 | Woo-Jung SongLorcan McGarvey+2 | ERS PublicationsChronic Cough | — | chronic coughantitussive+3 | — | 27m 02s | ||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 1/29/26 | cannabislung health+4 | Janice Leung | European Respiratory JournalCanadian Users of Cannabis Smoke study | — | cannabislung+5 | — | 13m 33s | ||
| 12/18/25 | year in reviewrespiratory health+3 | Don Sin | European Respiratory JournalERJ Podcast December 2025: Year in review+1 | — | European Respiratory JournalJames Chalmers+5 | — | 14m 41s | ||
| 12/15/25 | artificial intelligencescientific publishing+3 | Don SinRory Morty | European Respiratory JournalEur Respir J+1 | — | artificial intelligencepublishing+3 | — | 14m 01s | ||
| 10/31/25 | natural disastersrespiratory health+3 | Isabella Annesi-Maesano | European Respiratory JournalERJ Podcast October 2025: Natural disasters and respiratory health+2 | — | natural disastersrespiratory health+3 | — | 15m 04s | ||
| 10/23/25 | pulmonary hypertensiondiagnosis+3 | Gabor Kovacs | Pulmonary Hypertension | — | pulmonary hypertensiondiagnosis+3 | — | 21m 31s | ||
| 9/26/25 | ERJ Podcast September 2025: Neutrophil-derived biomarkers in bronchiectasis | As part of the September issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Associate Editor Marcus Mall about neutrophil-derived biomarkers in bronchiectasis, as discussed in his review article in this issue of the ERJ: https://doi.org/10.1183/13993003.00081-2025 Correction: At 5 min 54 s in this podcast, in response to a question from D. Sin regarding the dosing of azithromycin, M. Mall mistakenly replied that “For the immunomodulatory effects, it would be a standard long-term therapy with a three times per day regimen.” He meant to say “three times per week”. We apologise for this error. Cite this podcast as: ERJ Podcast September 2025: Neutrophil-derived biomarkers in bronchiectasis. Eur Respir J 2025; 55: 25E6603. [https://doi.org/10.1183/13993003.E6603-2025] | — | ||||||
| 9/15/25 | ERJ Podcast August 2025: Treatment of central sleep apnoea with adaptive servo-ventilation | As part of the August issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Winfried Randerath (Bethanien Hospital, Clinic of Pneumology and Allergology, Centre for Sleep Medicine and Respiratory Care, Institute of Pneumology at the University of Cologne, Solingen, Germany) about the European Respiratory Society and European Sleep Research Society statement on the treatment of central sleep apnoea with adaptive servo-ventilation in this issue of the ERJ: https://doi.org/10.1183/13993003.00263-2025 Cite this podcast as: ERJ Podcast August 2025: Treatment of central sleep apnoea with adaptive servo-ventilation. Eur Respir J 2025; 66: 25E6602 [doi.org/10.1183/13993003.E6602-2025]. | — | ||||||
| 8/13/25 |  ERS Monograph: Asthma | “We really need to celebrate the exciting times in asthma but also focus on the advocacy for improving outcomes in research and in clinical practice” Leading asthma experts David Jackson, Vanessa McDonald and Ian Pavord meet with Monograph Editorial Board member Dorina Esendagli to discuss their 500-page authoritative guide to the latest developments in the field. They discuss pathophysiology, treatable traits, biomarkers, comorbidities, the importance of the multidisciplinary team, and the personal experiences that gave them a genuine passion for helping asthma patients. | — | ||||||
| 7/31/25 | ERJ Podcast July 2025: Implementation of European national driving regulations for OSA | As part of the July issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Walter McNicholas (School of Medicine and the Conway Research Institute, University College Dublin, and Department of Respiratory and Sleep Medicine, St Vincent’s Hospital Group, Dublin, Ireland) about the challenges of implementing European national driving regulations for obstructive sleep apnoea, as discussed in Prof. McNicholas’ article in this issue of the ERJ: https://doi.org/10.1183/13993003.02484-2024 Cite this podcast as: ERJ Podcast July 2025: Implementation of European national driving regulations for OSA. Eur Respir J 2025; 66: 25E6601 [https://doi.org/10.1183/13993003.E6601-2025]. | — | ||||||
| 7/30/25 | ERJ Podcast January 2025: Treatment response to mepolizumab in severe eosinophilic asthma | As part of the January issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Dr Peter Gibson about distinct trajectories of treatment response to mepolizumab toward remission in patients with severe eosinophilic asthma. | — | ||||||
| 7/2/25 | ERJ Podcast June 2025: Mechanistic studies in interstitial lung disease | As part of the June issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Associate Editor Bruno Crestani about a series of articles published in the June issue of the ERJ on mechanistic studies in interstitial lung disease: building translational bridges in IPF research. | — | ||||||
| 5/29/25 | ERJ Podcast May 2025: Efficacy and safety of the activin signalling inhibitor sotatercept | As part of the May issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Associate Editor Marius Hoeper about the efficacy and safety of the activin signalling inhibitor sotatercept in a pooled analysis of PULSAR and STELLAR studies. | — | ||||||
| 5/1/25 | ERJ Podcast April 2025: Continuous positive airway pressure and mandibular advancement splints | As part of the April issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Dr Fernanda Almeida about the CHOICE multicentre, open-label randomised clinical trial. | — | ||||||
| 4/1/25 |  ERJ Podcast March 2025: Generalisability of pharmaceutical randomised controlled trial eligibility criteria for progressive pulmonary fibrosis | As part of the March issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Associate Editor Yet Khor about the generalisability of pharmaceutical randomised controlled trial eligibility criteria for progressive pulmonary fibrosis. | — | ||||||
| 2/26/25 | ERJ Podcast February 2025: Pre- and post-bronchodilator spirometry in COPD | As part of the February issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Associate Editor Dave Singh about pre- and post-bronchodilator spirometry in COPD. | — | ||||||
Showing 25 of 88
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.